Frost & Sullivan names Philips as the Enabling Technology Leader in Digital Pathology

Technology integration is a critical success factor for the digital pathology – healthcare informatics space. Yet, with a wide array of digital pathology solutions available, healthcare organizations must choose platforms that deliver meaningful clinical and operational impact.

With its artificial intelligence (AI)- enabled [3], cloud-enabled [4] IntelliSite Pathology Solution (PIPS) system, Philips Healthcare empowers labs to improve diagnostic accuracy and scale efficiently across multi-site networks. The system drives productivity gains of up to 37% [1] and reduces time to diagnosis by over 25% [5], while supporting real-time collaboration and seamless interoperability with hospital information technology systems. Frost & Sullivan recognizes that Philips Healthcare stands out from competitors through its consistent focus on innovation, adaptability, and practical application. Its PIPS system is already deployed across diverse care environments, from national reference labs to large academic medical centers, demonstrating its flexibility and robustness. Moreover, its open architecture enables vendor-agnostic integration with third-party scanners and AI tools, expanding its reach and impact. Combined with a customer-centric service model and global implementation expertise, Philips Healthcare has earned a strong reputation as a trusted leader in the digital pathology market, driving the future of diagnostics through intelligent, connected, and scalable solutions. With its strong overall performance, Philips Healthcare earns Frost & Sullivan’s 2025 Global Enabling Technology Leadership Recognition in the digital pathology and healthcare informatics industry.